Inventors: Tim Chisholm & Mohit Dhiman, Chemistry
The inventors have developed a new technique to identify and measure protein aggregates in the blood that arise in neurodegenerative diseases such as Parkinson’s. The technique is designed to detect these aggregates at biological concentrations and aims to provide an accurate diagnosis at the first presentation of symptoms.
Currently diseases such as Parkinsons are diagnosed symptomatically, leading to high rates of misdiagnosis until the disease develops further and new symptoms arise.
The inventors are currently focused on Parkinson’s as their first market, but expect that any disease with protein aggregates could be detected using this method.
The question for the i-Team is to analyse and identify the best route to market and the market entry strategy for this technology, including identifying early-stage sources of funding to enable the inventors to prove its efficacy at scale.